New members elected to Occlutech Board of Directors - 03 May 2021 17:00

SCHAFFHAUSEN, Switzerland, May 3, 2021 /PRNewswire-AsiaNet/ -- - Medical device company Occlutech Holding AG, one of the world's leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board Occlutech Holding AG ("Occlutech") today announc...

  Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer i... - 01 May 2021 20:06

SHANGHAI, May 1, 2021 /PRNewswire-Asianet/ -- In June, 2020, an academic paper on patients with COVID-19 inhaling hydrogen oxygen mixed gas produced by Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer was published in the Journal of Thoracic Disease. The multicenter, and open-labe...

  Essence Group Announces 'Peace of Mind' Strategy as Top Object... - 29 April 2021 09:01

HERZLIYA, Israel, April 29, 2021/PRNewswire-AsiaNet/ -- Leading IoT and AI Cloud Services Provider's New Corporate Vision to Remain at Forefront of R&D and Commercial Endeavors Essence Group [ https://www.essence-grp.com/ ], the major Israel-based R&D-focused designer and manufacturer of advanced s...

  Novaliq Announces More than 50% Patients Enrolled in CyclASol(... - 28 April 2021 22:00

HEIDELBERG, Germany and CAMBRIDGE, Mass., April 28, 2021 /PRNewswire-AsiaNet/ -- - Topline results expected in 2nd half 2021; 475 out of a 834 target patients randomized in ESSENCE-2 - Enrollment for 12-month safety extension trial (ESSENCE-2 OLE) completed - Phase 2B/3 Trial ESSENCE-1 Published in Cornea: The Journal of Cor...

  ERT and Bioclinica Close Merger, Creating the Global Leader in... - 28 April 2021 21:59

PHILADELPHIA, April 28, 2021 /PRNewswire-AsiaNet/ -- ERT ( https://c212.net/c/link/?t=0&l=en&o=3132623-1&h=2992466112&u=https%3A%2F%2Fwww.ert.com%2F&a=ERT ), a global leader in clinical endpoint data solutions, today announced the close of its merger with Bioclinica ( https://c212.net/c/link/?t=0&l=...

  Albumedix extends research collaboration with Cobra Biologics ... - 28 April 2021 11:00

NOTTINGHAM and KEELE, United Kingdom, April 28, 2021 /PRNewswire-AsiaNet/ -- -- Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers Albumedix Ltd. ('Albumedix') (https://albumedix.com/ ), an emerging leader in the e...

  HOYA Vision Care Releases Results of Three-Year MiYOSMART Spec... - 27 April 2021 23:33

BANGKOK, April 28, 2021 /PRNewswire-AsiaNet/ -- -- Strong evidence shows continued lens effectiveness in slowing myopia progression in children in third year HOYA Vision Care ( https://c212.net/c/link/?t=0&l=en&o=3142324-1&h=1257888903&u=https%3A%2F%2Fwww.hoyavision.com%2F&a=HOYA+...

  DiscGenics Completes Patient Enrollment in Japanese Clinical S... - 27 April 2021 11:23

SALT LAKE CITY and TOKYO, April 27, 2021 /PRNewswire-AsiaNet/ -- DiscGenics, Inc. ( https://www.discgenics.com/ ), a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, toda...

  Associates of Cape Cod, Inc. announces launch of PyroSmart Nex... - 24 April 2021 00:30

EAST FALMOUTH, Mass., April 24, 2021 /PRNewswire-AsiaNet/ -- Associates of Cape Cod, Inc. (ACC), a Seikagaku Group Company, announces the launch of a new, innovative, sustainable recombinant LAL reagent, PyroSmart NextGen(TM) for Bacterial Endotoxin Testing (BET). The new LAL reagent is sustainably produced...

  INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800 - 23 April 2021 22:00

PLYMOUTH MEETING, Pa., April 23, 2021 /PRNewswire-AsiaNet/ -- -- Given universal eligibility and broad availability of COVID-19 vaccines in the U.S., DoD JPEO-CBRND has notified INOVIO that it will discontinue funding for the Phase 3 INO-4800 trial -- INOVIO adjusts INO-4800 clinical dev...